Table 3.

Patient characteristics of patients with synchronous metastases: stage IV at diagnosis vs. metastases ≤6 months but not at diagnosis

	Stage IV at diagnosis (n = 50)		Metastases ≤6 months but not at diagnosis (n = 34)
Sex (ns)
Male	16	32 %	Stage II	Stage III	50 %
			3	14
Female	34	68 %	9	8	40 %
Age (ns)
Mean	53	(Range: 24–77)	51		(Range: 21–81)
Charlson Comorbidity Index (ns)
Mean	1.8		1.4
Survival (months, p = 0.003)
Median	7	(Range: 0–114)	23		(Range: 0–103)
Number of metastatic organs (p = 0.006)
1	25	50 %	27		79 %
≥2	25	50 %	7		21 %
Number of metastases (ns)
1–3 Metastases	14	28 %	11		33 %
4+ Metastases	36	72 %	23		67 %
Adrenalectomy (p = 0.001)
Yes	34	68 %	33		97 %
No	16	32 %	1		3 %
Diagnostic delay (months, ns)
Median	1.3	(Range: 0–11)	2.1		(Range: 0–33)

Significant differences between the two groups are indicated with a p value

ns not significant